|
1
|
Qamar AA, Grace ND, Groszmann RJ, et al:
Incidence, prevalence and clinical significance of abnormal
hematological indices in compensated cirrhosis. Clin Gastroenterol
Hepatol. 7:689–695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qamar AA and Grace ND: Abnormal
hematological indices in cirrhosis. Can J Gastroenterol.
23:441–445. 2009.PubMed/NCBI
|
|
3
|
Rois R, Sangro B, Herrero I, et al: The
role of thrombopoietin in the thrombocytopenia of patients with
live cirrhosis. Am J Gastroenterol. 100:1131–1136. 2005.
|
|
4
|
Sheehy T and Berman A: The anemia of
cirrhosis. J Lab Clin Med. 56:72–82. 1960.
|
|
5
|
Sullivan LW and Herbert V: Suppression of
hematopoiesis by ethanol. J Clin Invest. 43:2048–2062. 1964.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosenfeld SJ and Young NS: Viruses and
bone marrow failure. Blood Rev. 5:71–77. 1991. View Article : Google Scholar
|
|
7
|
Zhao S, Fu YM, Zhang WH, et al:
Alterations of bone marrow sinusoidal endothelium in rat and
patients with liver cirrhosis. Dig Dis Sci. 55:654–661. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kopp HG, Avecilla ST, Hooper AT and Rafii
S: The bone marrow vascular niche: home of HSC differentiation and
mobilization. Physiology. 20:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rafii S, Shapiro F, Rimarachin J, et al:
Isolation and characterization of human bone marrow microvascular
endothelial cells: hematopoietic progenitor cell adhesion. Blood.
84:10–19. 1994.PubMed/NCBI
|
|
10
|
Li WM, Huang WQ, Wang QR, et al: Positive
and negative haematopoietic cytokines produced by bone marrow
endothelial cells. Cytokine. 12:1017–1023. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bernad A, Kopf M, Kulbacki R, et al:
Interleukin-6 is required in vivo for the regulation of stem cells
and committed progenitors of the hematopoietic system. Immunity.
1:725–731. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schwertschlag US, Trepicchio WL, Dykstra
KH, et al: Hematopoietic, immunomodulatory and epithelial effects
of interleukin-11. Leukemia. 13:1307–1315. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sitnicka E, Ruscetti FW, Priestley GV, et
al: Transforming growth factor beta 1 directly and reversibly
inhibits the initial cell divisions of long-term repopulating
hematopoietic stem cells. Blood. 88:82–88. 1996.PubMed/NCBI
|
|
14
|
Fossati G, Mazzucchelli I, Gritti D, et
al: In vitro effects of GM-CSF on mature peripheral blood
neutrophils. Int J Mol Med. 1:943–951. 1998.
|
|
15
|
Kramann R, Couson SK, Neuss S, et al:
Uraemia disrupts the vascular niche in a 3D co-culture system of
human mesenchymal stem cells and endothelial cells. Nephrol Dial
Transplant. 27:2693–2702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tjandra SS, Hsu C, Goh YI, et al: IFN-beta
signaling positively regulates tumorigenesis in aggressive
fibromatosis, potentially by modulating mesench-ymal progenitors.
Cancer Res. 67:7124–7131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar
|
|
19
|
Ruhenstroth-Bauer G: The role of humoral
splenic factors in the formation and release of blood cells. Semin
Hematol. 2:229–248. 1965.PubMed/NCBI
|
|
20
|
Kansas GS: Selectins and their ligands:
current concepts and controversies. Blood. 88:3259–3287.
1996.PubMed/NCBI
|
|
21
|
Wagner DD and Frenette PS: The vessel wall
and its interactions. Blood. 111:5271–5281. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schweitzer CM, van der Schoot CE, Drager
AM, et al: Isolation and culture of human bone marrow endothelial
cells. Exp Hematol. 23:41–48. 1995.PubMed/NCBI
|
|
23
|
Pigott R, Dillon LP, Hemingway IH and
Gearing AJ: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are
present in the supernatant of cytokine activated cultured
endothelial cells. Biochem Biophys Res Commun. 187:584–589. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dejana E and Giampietro C: Vascular
endothelial-cadherin and vascular stability. Curr Opin Hematol.
19:218–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Le Guelte A and Gavard J: Role of
endothelial cell-cell junctions in endothelial permeability.
Methods Mol Biol. 763:265–279. 2011.PubMed/NCBI
|
|
26
|
Kim S, Bakre M, Yin H and Varner JA:
Inhibition of endothelial cell survival and angiogenesis by protein
kinase A. J Clin Invest. 110:933–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Widlak P: The DFF40/CAD endonuclease and
its role in apoptosis. Acta Biochim Pol. 47:1037–1044.
2000.PubMed/NCBI
|
|
28
|
Liebermann DA and Hoffman B: MyD genes in
negative growth control. Oncogene. 17:3319–3329. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shakibaei M, Schulze-Tanzil G, Takada Y
and Aggarwal BB: Redox regulation of apoptosis by members of the
TNF superfamily. Antioxid Redox Signal. 7:482–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kohler EE, Cowan CE, Wary KK, et al: NANOG
induction of fetal liver kinase-1 (FLK1) transcription regulates
endothelial cell proliferation and angiogenesis. Blood.
117:1761–1769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou W, Lin L, Evans SM, et al: Modulation
of morphogenesis by noncanonical Wnt signaling requires ATF/CREB
family-mediated transcriptional activation of TGFβ2. Nat Genet.
39:1225–1234. 2007.PubMed/NCBI
|
|
32
|
Nakajima M, Ogawa M, Shimoda Y, et al:
Presenilin-1 controls the growth and differentiation of endothelial
progenitor cells through its beta-catenin-binding region. Cell Biol
Int. 30:239–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mustonen T and Alitalo K: Endothelial
receptor tyrosine kinases involved in angiogenesis. J Cell Biol.
129:895–898. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou C and Wu S: T-type calcium channels
in pulmonary vascular endothelium. Microcirculation. 13:645–656.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van der Velden AW and Thoma AA: The role
of the 5 untranslated region of an mRNA in translation regulation
during development. Int J Biochem Cell Biol. 31:87–106.
1999.PubMed/NCBI
|
|
36
|
Broxmeyer HE and Williams DE: The
production of myeloid blood cells and their regulation during
health and disease. Crit Rev Oncol Hematol. 8:173–226. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zumkeller W: The insulin-like growth
factor system in hematopoietic cells. Leuk Lymphoma. 43:487–491.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Doh KO, Jung HK, Moon IJ, Kang HG, Park JH
and Park JG: Prevention of CCl4-induced liver cirrhosis by ribbon
antisense to transforming growth factor-β1. Int J Mol Med.
21:33–39. 2008.PubMed/NCBI
|
|
39
|
Skobin V, Jelkmann W, Morschakova E, et
al: Tumor necrosis factor-alpha and TNF-beta inhibit clonogenicity
of mobilized human hematopoietic progenitors. J Interferon Cytokine
Res. 20:507–510. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Broxmeyer HE, Cooper S, Li ZH, et al:
Macrophage-stimulating protein, a ligand for the RON receptor
protein tyrosine kinase, suppresses myeloid progenitor cell
proliferation and synergizes with vascular endothelial cell growth
factor and members of the chemokine family. Ann Hematol. 73:1–9.
1996. View Article : Google Scholar
|
|
41
|
Cheng LM and Wang QR: Hematopoietic
inhibitors elaborated by bone marrow endothelial cells. Zhongguo
Shi Yan Xue Ye Xue Za Zhi. 10:485–491. 2002.(In Chinese).
|
